Infectious Disease

Our commitment to the field of infectious diseases is an active one. We're expanding the knowledge base of this therapeutic area and empowering physicians to make evidence - based clinical decisions.

Our proud history of collaborating with investigators around the world provides ideal environments to study compounds that have the potential for significant breakthroughs and allows us to generate and publish key information on our advances. In fact, Astellas pioneered the empiric antifungal clinical trial and has performed some of the world's largest clinical trials in fungal infections.

This information is intended for U.S. residents only.

For information on Astellas' infectious disease products, see our Products page.

Copyright © 2005 - 2009 Astellas Pharma US, Inc.